Works matching DE "PROTEIN-tyrosine kinase inhibitors"

Results: 5000
    1
    2
    3

    Clinical Impact of Continuous Dasatinib Administration on the Prognosis of Patients With BCR::ABL1 Acute Lymphoblastic Leukemia: Result of the Prospective MRD2014 Study Conducted by Fukuoka Blood and Marrow Transplantation Group (FBMTG).

    Published in:
    European Journal of Haematology, 2025, v. 114, n. 6, p. 1001, doi. 10.1111/ejh.14407
    By:
    • Nagafuji, Koji;
    • Ito, Yoshikiyo;
    • Miyamoto, Toshihiro;
    • Eto, Tetsuya;
    • Kamimura, Tomohiko;
    • Kato, Koji;
    • Miyazaki, Yasuhiko;
    • Wake, Atsuhi;
    • Kohno, Kentaro;
    • Takase, Ken;
    • Imamura, Yutaka;
    • Uchida, Naoyuki;
    • Tanimoto, Kazuki;
    • Kawano, Noriaki;
    • Kurokawa, Toshiro;
    • Kondo, Yukio;
    • Fujisaki, Tomoaki;
    • Tsukada, Junichi;
    • Yonemoto, Koji;
    • Akashi, Koichi
    Publication type:
    Article
    4
    5
    6
    7
    8

    Different In Vitro Models of Chronic Myeloid Leukemia Show Different Characteristics: Biological Replicates Are Not Biologically Equivalent.

    Published in:
    Cell Biology International, 2025, v. 49, n. 5, p. 570, doi. 10.1002/cbin.70007
    By:
    • Cavalleri, Alessia;
    • Xhahysa, Besjana;
    • Mutti, Silvia;
    • Ferraro, Rosalba Monica;
    • Mazzoldi, Elena Laura;
    • Farina, Mirko;
    • Leoni, Alessandro;
    • Garuffo, Luca;
    • Trenta, Federica;
    • Re, Federica;
    • Radici, Vera;
    • Buttini, Eugenia Accorsi;
    • Morello, Enrico;
    • Magliano, Gabriele;
    • Cancelli, Valeria;
    • Giliani, Silvia Clara;
    • Malagola, Michele;
    • Russo, Domenico;
    • Bernardi, Simona
    Publication type:
    Article
    9
    10

    Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real‐World Data From 17 Italian Centers.

    Published in:
    Head & Neck, 2025, v. 47, n. 7, p. 2040, doi. 10.1002/hed.28124
    By:
    • Caspani, Francesca;
    • Cavalieri, Stefano;
    • Orlandi, Ester;
    • Bergamini, Cristiana;
    • Resteghini, Carlo;
    • Colombo, Elena;
    • Ottini, Arianna;
    • Nuzzolese, Imperia;
    • Alfieri, Salvatore;
    • Mirabile, Aurora;
    • Cassano, Alessandra;
    • Bossi, Paolo;
    • Ibrahim, Toni;
    • Cau, Maria Chiara;
    • Ghiani, Massimo;
    • Bertolini, Federica;
    • Ingargiola, Rossana;
    • Fontana, Giulia;
    • Licitra, Lisa;
    • Locati, Laura D.
    Publication type:
    Article
    11
    12

    Responsiveness of different MET tumour alterations to type I and type II MET inhibitors.

    Published in:
    Clinical & Translational Medicine, 2025, v. 15, n. 5, p. 1, doi. 10.1002/ctm2.70338
    By:
    • Murciano‐Goroff, Yonina R.;
    • Foglizzo, Valentina;
    • Chang, Jason;
    • Rekhtman, Natasha;
    • Sisk, Ann Elizabeth;
    • Gibson, Jamie;
    • Judka, Lia;
    • Clemens, Kristen;
    • Roa, Paola;
    • Ahmed, Shaza Sayed;
    • Bremer, Nicole V.;
    • Binaco, Courtney Lynn;
    • Muzungu, Sherifah Kemigisha;
    • Rodriguez, Estelamari;
    • Merrill, Madeline;
    • Sgroe, Erica;
    • Repetto, Matteo;
    • Stadler, Zsofia K.;
    • Berger, Michael F.;
    • Yu, Helena A.
    Publication type:
    Article
    13
    14
    15
    16
    17

    Rilzabrutinib for the Treatment of Immune Thrombocytopenia.

    Published in:
    European Journal of Haematology, 2025, v. 115, n. 1, p. 4, doi. 10.1111/ejh.14425
    By:
    • Labanca, Caterina;
    • Martino, Enrica Antonia;
    • Vigna, Ernesto;
    • Bruzzese, Antonella;
    • Mendicino, Francesco;
    • Caridà, Giulio;
    • Lucia, Eugenio;
    • Olivito, Virginia;
    • Manicardi, Veronica;
    • Amodio, Nicola;
    • Neri, Antonino;
    • Morabito, Fortunato;
    • Gentile, Massimo
    Publication type:
    Article
    18
    19

    Evaluation of the effectiveness and safety of avapritinib in real-world Spanish cases with gastrointestinal stromal tumor and D842V-PDGFRA mutation.

    Published in:
    Oncologist, 2025, v. 30, n. 5, p. 1, doi. 10.1093/oncolo/oyaf062
    By:
    • Hernández, Isaac Nuñez;
    • Palmero, Cristina Gómez;
    • Delgado, Juan Ramón;
    • Nuño, Ana;
    • González, Maria Ángeles Sala;
    • Ageitos, Ana González;
    • Aguilar, Héctor;
    • Miguel, Pablo Ayala de;
    • Condori, Elizabeth;
    • Beveridge, Roberto Díaz;
    • García, Jerónimo Martínez;
    • Marquina, Gloria;
    • Varela-Pose, Vanesa;
    • Rodríguez, Joel Veas;
    • Serrano, César
    Publication type:
    Article
    20
    21
    22
    23
    24

    Prevalence and molecular correlates of acquired EGFR resistance mutations in non-small cell lung cancer (NSCLC).

    Published in:
    Expert Review of Anticancer Therapy, 2025, v. 25, n. 6, p. 711, doi. 10.1080/14737140.2025.2491648
    By:
    • Raez, Luis E.;
    • Baca, Yasmine;
    • Ribeiro, Jennifer R.;
    • Nieva, Jorge J.;
    • Mamdani, Hirva;
    • Lopes, Gilberto;
    • Borghaei, Hossein;
    • Socinski, Mark;
    • Wozniak, Antoinette J.;
    • Vanderwalde, Ari;
    • Uribe, Carlos Carracedo;
    • Sumarriva, Daniel;
    • Khan, Hina;
    • Liu, Stephen V.;
    • Nagasaka, Misako
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32

    Treatment patterns and outcomes in hepatocellular carcinoma: Real-world experience in Greece from the retrospective OPAL study.

    Published in:
    Annals of Gastroenterology, 2025, v. 38, n. 2, p. 195, doi. 10.20524/aog.2025.0950
    By:
    • Koskinas, John;
    • Pantzios, Spyridon;
    • Deutsch, Melanie;
    • Koullias, Emmanuel;
    • Alexopoulou, Alexandra;
    • Kranidioti, Hariklia;
    • Michailidou, Elisavet;
    • Goulis, Ioannis;
    • Papagiouvanni, Ioanna;
    • Koutroubakis, Ioannis;
    • Samonakis, Dimitrios;
    • Drygiannakis, Ioannis;
    • Magafouraki, Eleni;
    • Tsaliki, Evdokia;
    • Manolakopoulos, Spilios;
    • Elefsiniotis, Ioannis;
    • Papatheodoridis, Georgios
    Publication type:
    Article
    33
    34
    35
    36
    37
    38

    Efficacy of Anlotinib Plus Docetaxel in Advanced NSCLC Previously Treated with Platinum-Based Chemotherapy: A Systematic Review and Meta-Analysis.

    Published in:
    Pharmaceuticals (14248247), 2025, v. 18, n. 5, p. 652, doi. 10.3390/ph18050652
    By:
    • Hetta, Helal F.;
    • Alqifari, Saleh F.;
    • Alshehri, Khaled;
    • Alhowiti, Amirah;
    • Alharbi, Saud S.;
    • Mirghani, Hyder;
    • Alrasheed, Tariq;
    • Mostafa, Mohamed E. A.;
    • Sheikh, Mohammed;
    • Elodemi, Mahmoud;
    • Alhumaid, Sultan A.;
    • Ramadan, Yasmin N.;
    • Abd Ellah, Noura H.;
    • Sayad, Reem
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Abdominal and intra-abdominal fibromatoses: Outcomes over time.

    Published in:
    American Journal of Clinical Pathology, 2025, v. 163, n. 5, p. 744, doi. 10.1093/ajcp/aqae182
    By:
    • Beshah, Fireneh N;
    • Sanchez-Avila, Monica;
    • Abulaban, Amr;
    • Montoya-Cerrillo, Diego;
    • Requena, Domenika Ortiz;
    • Kehinde, Temitope;
    • Livingstone, Alan S;
    • Hornicek, Francis J;
    • D'Amato, Gina;
    • Rosenberg, Andrew E;
    • Montgomery, Elizabeth A
    Publication type:
    Article
    48
    49
    50

    Mechanisms of drug resistance in hepatocellular carcinoma.

    Published in:
    Biological Procedures Online, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s12575-025-00281-6
    By:
    • Zou, Yongchun;
    • Wan, Xinliang;
    • Zhou, Qichun;
    • Zhu, Gangxing;
    • Lin, Shanshan;
    • Tang, Qing;
    • Yang, Xiaobing;
    • Wang, Sumei
    Publication type:
    Article